Glaucoma Research Today is a free monthly online journal that collates and summarizes the latest research about Glaucoma, including details on cataracts, surgery, treatment, blindness.

Volume 2 (2006), Issue 1 (January)

1. Comparison of retinal nerve fiber layer thickness and optic disk algorithms with optical coherence tomography to detect glaucoma.
   Am J Ophthalmol, 141(1): 105-115. [Abstract] [Full-text]
2. Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease.
   Am J Ophthalmol, 141(1): 24-30. [Abstract] [Full-text]
3. Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patients.
   J Ocul Pharmacol Ther, 21(6): 483-9. [Abstract] [Full-text]
4. Comparison of the effects of brimonidine 0.2% and timolol 0.5% on retinal nerve fiber layer thickness in ocular hypertensive patients: a prospective, unmasked study.
   J Ocul Pharmacol Ther, 21(6): 475-82. [Abstract] [Full-text]
5. Dorzolamide and timolol saves retinal ganglion cells in glaucomatous adult rats.
   J Ocul Pharmacol Ther, 21(6): 454-62. [Abstract] [Full-text]
6. Measurement of persistence and adherence to regimens of IOP-lowering glaucoma medications using pharmacy claims data.
   Am J Ophthalmol, 141(1): S28-33. [Abstract] [Full-text]
7. The glaucoma research foundation patient survey: patient understanding of glaucoma and its treatment.
   Am J Ophthalmol, 141(1): S22-7. [Abstract] [Full-text]
8. Cost-effectiveness of monotherapy treatment of glaucoma and ocular hypertension with the lipid class of medications.
   Am J Ophthalmol, 141(1): S15-21. [Abstract] [Full-text]
9. Evaluation of quality of life for patients with glaucoma.
   Am J Ophthalmol, 141(1): S3-14. [Abstract] [Full-text]
10. A 12-week, randomized, double-masked, multicenter study of the fixed combination of latanoprost and timolol in the evening versus the individual components.
    Ophthalmology, 113(1): 70-6. [Abstract] [Full-text]
11. Fluorescein filling defects of the optic nerve head in normal tension glaucoma, primary open-angle glaucoma, ocular hypertension and healthy controls.
    Ophthalmic Physiol Opt, 26(1): 26-32. [Abstract] [Full-text]
12. Managing 'suspicious glaucomatous discs' identified during digital-photography-based diabetic retinopathy screening.
    Ophthalmic Physiol Opt, 26(1): 19-25. [Abstract] [Full-text]
13. A comparison of the effects of 0.005% latanoprost and fixed combination dorzolamide/timolol on retrobulbar haemodynamics in previously untreated glaucoma patients.
    Curr Med Res Opin, 22(1): 67-73. [Abstract] [Full-text]
14. Scleral-fixated posterior chamber intraocular lenses in non-vitrectomized eyes.
    Eye, 20(1): 64-70. [Abstract] [Full-text]
15. Eyetrack (ET) vs the conventional paper record (CPR): a study comparing the accuracy and speed of data retrieval from glaucoma patient records.
    Eye, 20(1): 80-3. [Abstract] [Full-text]
16. Angle-closure glaucoma in East Asian and European people. Different diseases?
    Eye, 20(1): 3-12. [Abstract] [Full-text]
17. Pointwise linear progression criteria and the detection of visual field change in a glaucoma trial.
    Eye, 20(1): 98-106. [Abstract] [Full-text]
18. Predictive value of colour Doppler imaging in a prospective study of visual field progression in primary open-angle glaucoma.
    Acta Ophthalmol Scand, 83(6): 716-22. [Abstract] [Full-text]
19. Exfoliation syndrome in Nordic countries: a comparative histopathological study of Danish and Finnish eyes with absolute glaucoma and uveal melanoma.
    Acta Ophthalmol Scand, 83(6): 711-5. [Abstract] [Full-text]
20. Trabeculectomy and optic nerve head topography.
    Braz J Med Biol Res, 39(1): 149-55. [Abstract] [Full-text]
21. Novel myocilin mutation in a Chinese family with juvenile-onset open-angle glaucoma.
    Arch Ophthalmol, 124(1): 102-6. [Abstract] [Full-text]
22. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma.
    Arch Ophthalmol, 124(1): 12-9. [Abstract] [Full-text]
23. The emerging role of proteases in retinal ganglion cell death.
    Exp Eye Res, 82(1): 5-12. [Abstract] [Full-text]
24. Effects of acute delivery of endothelin-1 on retinal ganglion cell loss in the rat.
    Exp Eye Res, 82(1): 132-45. [Abstract] [Full-text]
25. 24-h blood pressure monitoring in normal tension glaucoma: night-time blood pressure variability.
    J Hum Hypertens, 20(2): 137-42. [Abstract] [Full-text]
26. A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies.
    Br J Ophthalmol, 90(2): 237-41. [Abstract] [Full-text]
27. A new quality assessment parameter for optical coherence tomography.
    Br J Ophthalmol, 90(2): 186-90. [Abstract] [Full-text]
28. Mitomycin C augmented glaucoma surgery: evolution of filtering bleb avascularity, transconjunctival oozing, and leaks.
    Br J Ophthalmol, 90(2): 175-80. [Abstract] [Full-text]
29. The rising cost of glaucoma drugs in Ireland 1996-2003.
    Br J Ophthalmol, 90(2): 162-5. [Abstract] [Full-text]
30. Anterior chamber depth measurement by optical pachymetry: systematic difference using the Haag-Streit attachments.
    Br J Ophthalmol, 90(2): 142-5. [Abstract] [Full-text]
31. Comparison of the use of new handheld tonometers and established applanation tonometers in dogs.
    Am J Vet Res, 67(1): 134-44. [Abstract] [Full-text]
32. Effect of experimental glaucoma in primates on oscillatory potentials of the slow-sequence mfERG.
    Invest Ophthalmol Vis Sci, 47(2): 753-67. [Abstract] [Full-text]
33. Heat shock protein 90 is an essential molecular chaperone for nuclear transport of glucocorticoid receptor beta.
    Invest Ophthalmol Vis Sci, 47(2): 700-8. [Abstract] [Full-text]
34. Correlation of asymmetric glaucomatous visual field damage and water-drinking test response.
    Invest Ophthalmol Vis Sci, 47(2): 641-4. [Abstract] [Full-text]
35. Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo.
    Invest Ophthalmol Vis Sci, 47(2): 626-33. [Abstract] [Full-text]
36. A large GLC1C Greek family with a myocilin T377M mutation: inheritance and phenotypic variability.
    Invest Ophthalmol Vis Sci, 47(2): 620-5. [Abstract] [Full-text]
37. A case of glaucomatocyclitic crisis in the emergency department.
    Ann Emerg Med, 47(2): 167-9. [Abstract] [Full-text]
38. Expression of phosphorylated c-Jun N-terminal protein kinase (JNK) in experimental glaucoma in rats.
    Exp Eye Res, 82(4): 576-82. [Abstract] [Full-text]
39. Latanoprost therapy reduces the levels of TGF beta 1 and gelatinases in the aqueous humour of patients with exfoliative glaucoma.
    Exp Eye Res, 82(2): 319-22. [Abstract] [Full-text]
40. Characterization of retinal damage in the episcleral vein cauterization rat glaucoma model.
    Exp Eye Res, 82(2): 219-28. [Abstract] [Full-text]
41. Socioeconomic differences in glaucoma patients' knowledge, need for information and expectations of treatments.
    Acta Ophthalmol Scand, 84(1): 84-91. [Abstract] [Full-text]
42. A multicentre, retrospective study of resource utilization and costs associated with glaucoma management in France and Sweden.
    Acta Ophthalmol Scand, 84(1): 74-83. [Abstract] [Full-text]
43. Cardiovascular risk factors and events in glaucoma patients with peripapillary focal arteriolar narrowing.
    Acta Ophthalmol Scand, 84(1): 69-73. [Abstract] [Full-text]

© 2005-2013 Glaucoma Research Today. All Rights Reserved.